Findings from our study also support this notion, as there was a trend for lower drug persistency in obese patients, but this finding did not reach statistical significance.
← all excerpts
Treatment persistence of biologics among patients with psoriatic arthritis.
2
—
—
The sentences
Notably, secukinumab only narrowly missed statistical significance for superiority over adalimumab in the primary endpoint of the head-to-head EXCEED trial, showing only numerically higher results versus adalimumab [ 13 ].